See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Jayachandran Kizhakkedathu

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	40999753	0	Dinjoo E, Kulka MW, Malek Mohammadi Nouri P, et al. A-BioHPG: A Hydrophilic Biodegradable and Hemocompatible Hyperbranched/Dendritic Polyketal Polyglycerol with Tunable Degradation. Biomacromolecules. 2025 Oct 13;26(10):7108-7124. doi: 10.1021/acs.biomac.5c01458. Epub 2025 Sep 25.
	40132149	0	Rauova L, Bdeir K, Rux AH, et al. Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia. Blood. 2025 Mar 25:blood.2024025653. doi: 10.1182/blood.2024025653.
	39533064	0	Ji H, Yu K, Abbina S, et al. Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII-biointerface binding. Nat Mater. 2025 Apr;24(4):626-636. doi: 10.1038/s41563-024-02046-0. Epub 2024 Nov 12.
	38537246	0	La CC, Smith SA, Kalathottukaren MT, et al. External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote. Adv Healthc Mater. 2024 Aug;13(20):e2400108. doi: 10.1002/adhm.202400108. Epub 2024 Apr 3.
	37573353	0	Xu T, Ji H, Xu L, et al. Self-anticoagulant sponge for whole blood auto-transfusion and its mechanism of coagulation factor inactivation. Nat Commun. 2023 Aug 12;14(1):4875. doi: 10.1038/s41467-023-40646-7.
	37361105	0	Ji H, Li Y, Su B, et al. Advances in Enhancing Hemocompatibility of Hemodialysis Hollow-Fiber Membranes. Adv Fiber Mater. 2023 Apr 3:1-43. doi: 10.1007/s42765-023-00277-5.
	37192652	0	Vappala S, Smith SA, Kizhakkedathu JN, et al. Inhibitors of Polyphosphate and Neutrophil Extracellular Traps. Semin Thromb Hemost. 2024 Oct;50(7):970-977. doi: 10.1055/s-0043-1768936. Epub 2023 May 16.
	37100783	0	La CC, Smith SA, Vappala S, et al. Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design. Nat Commun. 2023 Apr 26;14(1):2177. doi: 10.1038/s41467-023-37709-0.
	35500201	0	Abbina S, La CC, Vappala S, et al. Influence of Steric Shield on Biocompatibility and Antithrombotic Activity of Dendritic Polyphosphate Inhibitor. Mol Pharm. 2022 Jun 6;19(6):1853-1865. doi: 10.1021/acs.molpharmaceut.1c00934. Epub 2022 May 2.
	34600430	0	Yeh HH, Yu K, Vappala S, et al. Rheological and clot microstructure evaluation of heparin neutralization by UHRA and protamine. J Mech Behav Biomed Mater. 2021 Dec;124:104851. doi: 10.1016/j.jmbbm.2021.104851. Epub 2021 Sep 24.
	34415324	0	Kizhakkedathu JN, Conway EM. Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet. Blood. 2022 Mar 31;139(13):1987-1998. doi: 10.1182/blood.2020007209.
	32497427	0	La CC, Takeuchi LE, Abbina S, et al. Targeting Biological Polyanions in Blood: Strategies toward the Design of Therapeutics. Biomacromolecules. 2020 Jul 13;21(7):2595-2621. doi: 10.1021/acs.biomac.0c00654. Epub 2020 Jun 19.
	30135185	0	Kalathottukaren MT, Creagh AL, Abbina S, et al. Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors. Blood Adv. 2018 Aug 28;2(16):2104-2114. doi: 10.1182/bloodadvances.2016003616.
	30085650	0	Meneksedag-Erol D, Kizhakkedathu JN, Tang T, et al. Molecular Dynamics Simulations on Nucleic Acid Binding Polymers Designed To Arrest Thrombosis. ACS Appl Mater Interfaces. 2018 Aug 29;10(34):28399-28411. doi: 10.1021/acsami.8b09914. Epub 2018 Aug 20.
	29549767	0	Yu K, Andruschak P, Yeh HH, et al. Influence of dynamic flow conditions on adsorbed plasma protein corona and surface-induced thrombus generation on antifouling brushes. Biomaterials. 2018 Jun;166:79-95. doi: 10.1016/j.biomaterials.2018.03.009. Epub 2018 Mar 8.
	29539260	0	Mafi A, Abbina S, Kalathottukaren MT, et al. Design of Polyphosphate Inhibitors: A Molecular Dynamics Investigation on Polyethylene Glycol-Linked Cationic Binding Groups. Biomacromolecules. 2018 Apr 9;19(4):1358-1367. doi: 10.1021/acs.biomac.8b00327. Epub 2018 Mar 23.
	28880550	0	Kalathottukaren MT, Abbina S, Yu K, et al. A Polymer Therapeutic Having Universal Heparin Reversal Activity: Molecular Design and Functional Mechanism. Biomacromolecules. 2017 Oct 9;18(10):3343-3358. doi: 10.1021/acs.biomac.7b00994. Epub 2017 Sep 19.
	28741113	0	Kalathottukaren MT, Haynes CA, Kizhakkedathu JN. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments. Drug Deliv Transl Res. 2018 Aug;8(4):928-944. doi: 10.1007/s13346-017-0413-4.
	28034889	0	Kalathottukaren MT, Abraham L, Kapopara PR, et al. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. Blood. 2017 Mar 9;129(10):1368-1379. doi: 10.1182/blood-2016-10-747915. Epub 2016 Dec 29.
	27818307	0	Brockman KS, Kizhakkedathu JN, Santerre JP. Hemocompatibility studies on a degradable polar hydrophobic ionic polyurethane (D-PHI). Acta Biomater. 2017 Jan 15;48:368-377. doi: 10.1016/j.actbio.2016.11.005. Epub 2016 Nov 3.
	26295533	0	Yu K, Lai BF, Gani J, et al. Interaction of blood components with cathelicidins and their modified versions. Biomaterials. 2015 Nov;69:201-11. doi: 10.1016/j.biomaterials.2015.08.003. Epub 2015 Aug 6.
	26280734	0	Narain R, Wang Y, Ahmed M, et al. Blood Components Interactions to Ionic and Nonionic Glyconanogels. Biomacromolecules. 2015 Sep 14;16(9):2990-7. doi: 10.1021/acs.biomac.5b00890. Epub 2015 Aug 21.
	25664972	0	Kumar P, Shenoi RA, Lai BF, et al. Conjugation of aurein 2.2 to HPG yields an antimicrobial with better properties. Biomacromolecules. 2015 Mar 9;16(3):913-23. doi: 10.1021/bm5018244. Epub 2015 Feb 20.
	25516628	0	Sabino F, Hermes O, Egli FE, et al. In vivo assessment of protease dynamics in cutaneous wound healing by degradomics analysis of porcine wound exudates. Mol Cell Proteomics. 2015 Feb;14(2):354-70. doi: 10.1074/mcp.M114.043414. Epub 2014 Dec 16.